Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus

被引:7
作者
Awadallah, Samir M. [1 ]
Saleh, Suleiman A. [1 ]
Abu Shaqra, Qasem M. [2 ]
Hilow, Hisham [3 ]
机构
[1] Hashemite Univ, Dept Med Lab Sci, Zarqa 13133, Jordan
[2] Diagnost Med Labs, Zarqa 13111, Jordan
[3] Univ Jordan, Dept Math, Amman 11942, Jordan
关键词
Cystatin C; Microalbuminuria; Diabetes; Haptoglobin;
D O I
10.1016/j.jdiacomp.2007.07.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent studies have suggested an inheritable influence of haptoglobin phenotypes on the development of microalbuminuria in diabetic patients. In this study, we aimed to investigate whether microalbuminuria and serum levels of Cystatin C (Cys C) were correlated with haptoglobin phenotypes in patients with Type 2 diabetes mellitus. Methods: Fasting blood samples and first morning urine specimens were collected from 216 patients with type 2 diabetes (mean age 60.8 +/- 6.8) and from 108 healthy controls (mean age 59.3 +/- 6.5 years). Serum was used for the determination of Cys C, creatinine, and haptoglobin (Hp) phenotypes, while urine specimens were used for the determination of microalbuminuria. Microalbuminuria was expressed as albumin (mg)/creatinine (g) ratio [ACR (mg/g)], and patients were divided into three groups according to the values of ACR: normoalbuminuria ( <30), microalbuminuria (30-300) and macroalbuminuria ( > 300). Results: Irrespective of Hp phenotypes, Cys C, but not creatinine, was significantly higher in patients than that in controls. According to haptoglobin phenotypes, however, the levels of Cys C, duration of diabetes, and age, were significantly higher in patients with Hp1-1 phenotype than that in patients with the other phenotypes. Moreover, micro- and/or macroalbuminuria were present in all diabetic patients, with no significant difference in frequency of occurrence among the three Hp phenotypes. Multiple linear regression revealed that duration of diabetes and age of patient were significant predictors of Cys C (P < .0001), whereas creatinine associated with age only (P = .016). Logistic regression analysis showed that duration of diabetes [P <= .0001; odds ratio (OR) = 1.678, 95% CI = 1.43-1.97], and age (P = .0004; OR = 0.847, 95% CI = 0.77-0.93), significantly associated with micro- and/or macroalbuminuria. Hp phenotypes however, were not associated with any marker of kidney function. Conclusion: Findings from this study demonstrate no association between Hp phenotypes and markers of diabetic nephropathy. Markers of diabetic nephropathy however, are greatly influenced by duration of diabetes and age of patients. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:384 / 388
页数:5
相关论文
共 19 条
[1]   β2-microglobulin and cystatin C in type 2 diabetes:: Assessment of diabetic nephropathy [J].
Aksun, SA ;
Özmen, D ;
Özmen, B ;
Parildar, Z ;
Mutaf, I ;
Turgan, N ;
Habif, S ;
Kumanliogluc, K ;
Bayindir, O .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2004, 112 (04) :195-200
[2]  
American Diabetes Association, 2003, DIABETES CARE S1, V26, pS94
[3]  
American Diabetes Association, 2001, DIABETES CARE S1, V24, pS69
[4]   In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease [J].
Asleh, Rabea ;
Levy, Andrew .
VASCULAR HEALTH AND RISK MANAGEMENT, 2005, 1 (01) :19-28
[5]  
Awadallah S, 2000, CYTOBIOS, V101, P145
[6]   Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment [J].
Coll, E ;
Botey, A ;
Alvarez, L ;
Poch, E ;
Quintó, L ;
Saurina, A ;
Vera, M ;
Piera, C ;
Darnell, A .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (01) :29-34
[7]   Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis [J].
Dharnidharka, VR ;
Kwon, C ;
Stevens, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (02) :221-226
[8]   Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [J].
Eknoyan, G ;
Hostetter, T ;
Bakris, GL ;
Hebert, L ;
Levey, AS ;
Parving, HH ;
Steffes, MW ;
Toto, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (04) :617-622
[9]   Serum cystatin C concentration as a marker of renal dysfunction in the elderly [J].
Fliser, D ;
Ritz, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (01) :79-83
[10]   Cystatin C - Properties and use as diagnostic marker [J].
Grubb, AO .
ADVANCES IN CLINICAL CHEMISTRY, VOL 35, 2001, 35 :63-99